Cardlytics Non Current Liabilities Total vs Total Stockholder Equity Analysis

CDLX Stock  USD 4.02  0.09  2.29%   
Cardlytics financial indicator trend analysis is way more than just evaluating Cardlytics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cardlytics is a good investment. Please check the relationship between Cardlytics Non Current Liabilities Total and its Total Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Non Current Liabilities Total vs Total Stockholder Equity

Non Current Liabilities Total vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cardlytics Non Current Liabilities Total account and Total Stockholder Equity. At this time, the significance of the direction appears to have no relationship.
The correlation between Cardlytics' Non Current Liabilities Total and Total Stockholder Equity is 0.02. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Cardlytics, assuming nothing else is changed. The correlation between historical values of Cardlytics' Non Current Liabilities Total and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Cardlytics are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Non Current Liabilities Total i.e., Cardlytics' Non Current Liabilities Total and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.02
Relationship DirectionPositive 
Relationship StrengthInsignificant

Non Current Liabilities Total

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from Cardlytics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cardlytics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.Tax Provision is expected to grow at the current pace this year, whereas Selling General Administrative is likely to drop slightly above 48.4 M in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization33.7M43.7M29.5M16.7M
Interest Income297K1.4M3.8M3.4M

Cardlytics fundamental ratios Correlations

0.770.970.960.950.690.320.680.910.11-0.620.160.750.97-0.33-0.190.770.750.860.84-0.540.710.320.82-0.210.87
0.770.750.720.630.20.510.490.690.47-0.810.060.640.7-0.31-0.061.00.640.850.87-0.630.930.590.82-0.20.75
0.970.750.990.90.620.330.540.930.23-0.670.240.620.98-0.36-0.320.750.620.860.83-0.50.70.330.83-0.220.86
0.960.720.990.870.640.270.520.930.21-0.640.350.60.98-0.45-0.410.710.60.820.78-0.390.660.340.79-0.290.81
0.950.630.90.870.660.430.770.84-0.08-0.540.00.80.88-0.21-0.060.640.80.850.81-0.580.60.020.79-0.150.91
0.690.20.620.640.66-0.380.420.62-0.240.050.230.390.76-0.08-0.140.190.390.280.25-0.180.120.250.240.010.34
0.320.510.330.270.43-0.380.420.270.25-0.76-0.350.490.16-0.070.150.540.490.710.71-0.550.62-0.250.72-0.090.7
0.680.490.540.520.770.420.420.43-0.39-0.28-0.230.980.51-0.250.270.490.980.590.58-0.420.47-0.040.52-0.280.7
0.910.690.930.930.840.620.270.430.27-0.650.360.50.94-0.44-0.480.690.50.820.77-0.410.630.310.8-0.350.75
0.110.470.230.21-0.08-0.240.25-0.390.27-0.690.29-0.270.2-0.18-0.440.47-0.270.280.3-0.170.610.560.47-0.030.1
-0.62-0.81-0.67-0.64-0.540.05-0.76-0.28-0.65-0.69-0.04-0.41-0.580.280.24-0.83-0.41-0.85-0.870.57-0.91-0.33-0.940.16-0.75
0.160.060.240.350.00.23-0.35-0.230.360.29-0.04-0.240.31-0.75-0.860.0-0.24-0.08-0.10.63-0.030.340.03-0.48-0.19
0.750.640.620.60.80.390.490.980.5-0.27-0.41-0.240.57-0.240.270.641.00.70.71-0.530.60.080.62-0.250.78
0.970.70.980.980.880.760.160.510.940.2-0.580.310.57-0.35-0.350.690.570.780.75-0.440.640.390.76-0.190.77
-0.33-0.31-0.36-0.45-0.21-0.08-0.07-0.25-0.44-0.180.28-0.75-0.24-0.350.76-0.24-0.24-0.21-0.18-0.44-0.26-0.29-0.30.89-0.13
-0.19-0.06-0.32-0.41-0.06-0.140.150.27-0.48-0.440.24-0.860.27-0.350.76-0.010.27-0.07-0.02-0.48-0.07-0.23-0.210.620.04
0.771.00.750.710.640.190.540.490.690.47-0.830.00.640.69-0.24-0.010.640.870.89-0.690.930.550.83-0.160.78
0.750.640.620.60.80.390.490.980.5-0.27-0.41-0.241.00.57-0.240.270.640.70.71-0.530.60.080.62-0.250.78
0.860.850.860.820.850.280.710.590.820.28-0.85-0.080.70.78-0.21-0.070.870.70.99-0.730.830.190.94-0.150.96
0.840.870.830.780.810.250.710.580.770.3-0.87-0.10.710.75-0.18-0.020.890.710.99-0.730.850.240.93-0.10.94
-0.54-0.63-0.5-0.39-0.58-0.18-0.55-0.42-0.41-0.170.570.63-0.53-0.44-0.44-0.48-0.69-0.53-0.73-0.73-0.65-0.1-0.63-0.32-0.74
0.710.930.70.660.60.120.620.470.630.61-0.91-0.030.60.64-0.26-0.070.930.60.830.85-0.650.530.9-0.160.74
0.320.590.330.340.020.25-0.25-0.040.310.56-0.330.340.080.39-0.29-0.230.550.080.190.24-0.10.530.23-0.150.03
0.820.820.830.790.790.240.720.520.80.47-0.940.030.620.76-0.3-0.210.830.620.940.93-0.630.90.23-0.180.89
-0.21-0.2-0.22-0.29-0.150.01-0.09-0.28-0.35-0.030.16-0.48-0.25-0.190.890.62-0.16-0.25-0.15-0.1-0.32-0.16-0.15-0.18-0.11
0.870.750.860.810.910.340.70.70.750.1-0.75-0.190.780.77-0.130.040.780.780.960.94-0.740.740.030.89-0.11
Click cells to compare fundamentals

Cardlytics Account Relationship Matchups

Cardlytics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets224.3M422.5M1.3B691.2M574.1M440.0M
Short Long Term Debt Total37K188.1M197.2M235.3M266.1M140.6M
Other Current Liab76.0M70.1M313.4M238.5M162.2M125.5M
Total Current Liabilities78.4M81.3M327.4M248.9M171.1M135.4M
Total Stockholder Equity143.3M157.2M690.7M211.6M134.8M98.0M
Other Liab2.6M679K54.5M334K384.1K364.9K
Net Tangible Assets139.1M150.4M(190.5M)158.1M181.8M190.9M
Property Plant And Equipment Net14.3M24.6M21.5M12.5M10.6M14.5M
Current Deferred Revenue1.1M349K3.3M1.8M2.4M1.3M
Net Debt(104.4M)(105.1M)(36.2M)113.4M174.3M183.0M
Retained Earnings(338.6M)(394.1M)(522.6M)(976.6M)(1.1B)(1.1B)
Accounts Payable1.2M1.4M4.6M3.8M4.4M3.2M
Cash104.5M293.2M233.5M121.9M91.8M116.8M
Non Current Assets Total28.6M36.9M905.1M441.2M350.2M226.1M
Non Currrent Assets Other10.1M5.6M2.4M2.6M2.7M2.6M
Other Assets10.1M22.6M2.4M2.6M2.3M2.2M
Long Term Debt13K174.0M184.4M226.0M257.6M130.8M
Cash And Short Term Investments104.5M293.2M233.5M121.9M91.8M116.8M
Net Receivables85.4M86.6M117.2M120.1M126.0M89.2M
Common Stock Shares Outstanding23.7M27.2M32.2M33.4M36.5M26.9M
Long Term Debt Total13K174.0M184.4M226.0M260.0M273.0M
Liabilities And Stockholders Equity224.3M422.5M1.3B691.2M574.1M440.0M
Non Current Liabilities Total2.6M184.1M245.7M230.7M268.2M206.5M
Capital Surpluse480.6M551.4M1.2B1.2B1.4B1.4B
Inventory129K110K95K80K72K68.4K
Other Current Assets5.8M5.8M8.1M8.1M6.1M5.2M
Other Stockholder Equity480.6M551.4M1.2B1.2B1.2B628.4M
Total Liab81.0M265.3M573.1M479.6M439.3M342.0M
Deferred Long Term Liab8.5M3.8M139K198K178.2K169.3K
Property Plant And Equipment Gross14.3M24.6M11.3M5.9M43.7M45.9M
Total Current Assets195.7M385.6M358.7M250.0M223.9M213.8M
Accumulated Other Comprehensive Income1.3M(192K)486K5.6M2.5M1.9M
Short Term Debt24K9.5M6.1M4.9M2.1M4.0M
Intangible Assets4.2M6.7M138.7M73.4M59.6M35.1M
Property Plant Equipment14.3M13.9M21.5M5.9M6.8M12.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.